-
Product Insights
Aetna Realty/ Cornerstone CDC/ CVS Health Corp/ Winterwood Dev – Prichard Building Renovation – West Virginia
The Aetna Realty/ Cornerstone CDC/ CVS Health Corp/ Winterwood Dev – Prichard Building Renovation – West Virginia involves the renovation of the Prichard Hotel Building in Downtown Huntington into an affordable housing location for seniors in Huntington, West Virginia. Equip yourself with the essential tools needed to make informed and profitable decisions with our Aetna Realty/ Cornerstone CDC/ CVS Health Corp/ Winterwood Dev – Prichard Building Renovation – West Virginia report. Note: This is an on-demand report that will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Devimistat in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Devimistat in Sarcomas Drug Details: Devimistat (CPI-613) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Devimistat in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Ewing Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Devimistat in Ewing Sarcoma Drug Details: Devimistat (CPI-613) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Devimistat in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Devimistat in Soft Tissue Sarcoma Drug Details: Devimistat (CPI-613) is...
-
Sector Analysis
Europe Fibercos and Towercos Market Dynamics and Opportunities
Europe Fibercos and Towercos Market Report Overview Fibercos and towercos in Europe are heading toward organic growth strategies for controlling debts and sustaining rollout targets. Furthermore, infrastructure companies are trying to reduce their carbon emissions by generating power to support their operations. Large consumer base and favorable regulatory environment in Europe have made the region the most viable choice for investments from international telecommunications players. Additionally, a surge in demand for high-speed connectivity in the European economies is encouraging telecom...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Devimistat in Burkitt Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Burkitt Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Devimistat in Burkitt Lymphoma Drug Details: Devimistat (CPI-613) is under development for...
-
Company Insights
Kingfisher – Digital Transformation Strategies
Kingfisher Digital Transformation Strategies Overview Kingfisher has been focusing on using artificial intelligence, cloud-based mobile applications, big data, and augmented reality to digitally transform its operations. The annual ICT spending of Kingfisher was estimated at $369.9 million for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Kingfisher sells home improvement products and offers home improvement services to consumers and trade professionals in eight European countries. It operates under the B&Q,...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...